Detalhe da pesquisa
1.
Insulin/IGF-1 Drives PERIOD Synthesis to Entrain Circadian Rhythms with Feeding Time.
Cell
; 177(4): 896-909.e20, 2019 05 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31030999
2.
New Associations between Drug-Induced Adverse Events in Animal Models and Humans Reveal Novel Candidate Safety Targets.
Chem Res Toxicol
; 34(2): 438-451, 2021 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33338378
3.
A semi-quantitative translational pharmacology analysis to understand the relationship between in vitro ENT1 inhibition and the clinical incidence of dyspnoea and bronchospasm.
Toxicol Appl Pharmacol
; 317: 41-50, 2017 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28041785
4.
A practical guide to secondary pharmacology in drug discovery.
J Pharmacol Toxicol Methods
; 105: 106869, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-32302774
5.
In vitro secondary pharmacological profiling: An IQ-DruSafe industry survey on current practices.
J Pharmacol Toxicol Methods
; 93: 7-14, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30030184
6.
Triaminopyrimidine is a fast-killing and long-acting antimalarial clinical candidate.
Nat Commun
; 6: 6715, 2015 Mar 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-25823686